Ravi Manoharan

4PUBLICATIONS
6CO-AUTHORS
ChemotherapyBiologically active moleculesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 16, 2026
Cytotoxic effect of ruthenium-arene complexes containing tetrazolo[1,5-a] quinoline derivatives on cervical (HeLa), lung (A549), and colon (HCT116) cancer cell lines.

S Navitha, A S W Wilfred Raj, S Sree Brindha

|Apr 14, 2022
Diosgenin derivatives developed from Pd(II) catalysed dehydrogenative coupling exert an effect on breast cancer cells by abrogating their growth and facilitating apoptosis via regulating the AKT1 pathway.

S Dharani, G Kalaiarasi, M Ravi

|Jan 20, 2022
MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR/HIF-1α and p53 pathways.

Lavanya Ponnusamy, Sathan Raj Natarajan, Ravi Manoharan

|Jun 01, 2018
Dual Roles of Serine-Threonine Kinase Receptor-Associated Protein (STRAP) in Redox-Sensitive Signaling Pathways Related to Cancer Development.

Ravi Manoharan, Hyun-A Seong, Hyunjung Ha

Pageof 1

Frequent Collaborators

2 joint publications

Sathan Raj Natarajan

2 joint publications

R Prabhakaran

1 joint publications

G Kalaiarasi

1 joint publications

G Prabusankar